Back to NewEdge Advisors, LLC NewEdge Advisors, LLC

LTRNLTRN
Showing 8 of 21 quarters

Position history for NewEdge Advisors, LLCNewEdge Advisors, LLC's holdings in LANTERN PHARMA INC

NewEdge Advisors, LLC holds 27,049 shares of LTRN (LANTERN PHARMA INC), worth $112,796 as of 2026-Q2. The position was decreased (-1.3% shares). LTRN represents 0.0% of NewEdge Advisors, LLC's portfolio.

Current Value

$112,796

Current Shares

27,049

Total Value Change

-$391,249

Total Shares Change

-110,289

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
27,049
-1.3%
$112,7960.0%$4.17
0
2026-Q1
Decreased
27,399
-28.0%
$37,5420.0%$2.71
0
2025-Q4
Decreased
38,069
-19.5%
$115,3540.0%$3.06
0
2025-Q3
Decreased
47,279
-16.3%
$205,6740.0%$4.54
0
2025-Q2
Decreased
56,507
-5.7%
$178,5610.0%$3.19
0
2025-Q1
Decreased
59,924
-12.3%
$212,1330.0%$3.55
0
2024-Q4
Decreased
68,359
-50.2%
$218,0740.0%$3.27
0
2024-Q3
Decreased
137,338
-12.6%
$504,0450.0%$3.78
0

Other major holders of LTRN: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used